(Q30354452)

20 June 2017

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. (English)

1 reference

20 June 2017

0 references

24

Nicola Klein

1 reference

20 June 2017

25

Kathryn Edwards

1 reference

20 June 2017

1

Neal A Halsey

1 reference

20 June 2017

23

Roger Baxter

1 reference

20 June 2017

12

Claudia Vellozzi

1 reference

20 June 2017

11

Tina Proveaux

1 reference

20 June 2017

4

Cornelia L Dekker

1 reference

20 June 2017

8

Philip S LaRussa

1 reference

20 June 2017

3

Stephen C Dreskin

1 reference

20 June 2017

Mari Griffioen

2

1 reference

20 June 2017

Robert Wood

5

1 reference

20 June 2017

Devindra Sharma

6

1 reference

20 June 2017

James F Jones

7

1 reference

20 June 2017

Jenny Garner

9

1 reference

20 June 2017

Melvin Berger

10

1 reference

20 June 2017

Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network

13

1 reference

20 June 2017

Karen Broder

14

1 reference

20 June 2017

Rosanna Setse

15

1 reference

20 June 2017

Barbara Pahud

16

1 reference

20 June 2017

David Hrncir

17

1 reference

20 June 2017

Howard Choi

18

1 reference

20 June 2017

Robert Sparks

19

1 reference

20 June 2017

Sarah Elizabeth Williams

20

1 reference

20 June 2017

Renata J Engler

21

1 reference

20 June 2017

Jane Gidudu

22

1 reference

20 June 2017

Maria Cano

26

1 reference

20 June 2017

John M Kelso

27

1 reference

20 June 2017

language of work or name

English

0 references

publication date

8 October 2013

1 reference

20 June 2017

1 reference

20 June 2017

31

1 reference

20 June 2017

51

1 reference

20 June 2017

6107-6112

1 reference

Risk of Anaphylaxis After Vaccination of Children and Adolescents

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Anaphylaxis pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

The diagnosis and management of anaphylaxis practice parameter: 2010 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Emergency department anaphylaxis: A review of 142 patients in a single year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Severe allergic reactions to food in Norway: a ten year survey of cases reported to the food allergy register

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Immediate-type drug hypersensitivity and associated factors in a general population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Improving anaphylaxis management in a pediatric emergency department

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Allergen immunotherapy: a practice parameter third update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Administration of influenza vaccines to patients with egg allergy: Update for the 2010-2011 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.066

10.1016/J.VACCINE.2013.09.066

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference